We thank those who wrote in regard to our study “Rectal Indomethacin Does not Prevent Post-ERCP Pancreatitis (PEP) in Consecutive Patients” which was recently published in Gastroenterology.1 Clearly this is an important topic, and I appreciate the opportunity to respond to the letter writers on behalf of my co-authors.